Robert E Landry Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert E Landry.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Robert E Landry for August 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | M | 272.70 | 2,000 | 545,400 | 62,000 | |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 478.61 | 100 | 47,861 | 7,099 | 7.2 K to 7.1 K (-1.39 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 477.10 | 168 | 80,153 | 7,199 | 7.4 K to 7.2 K (-2.28 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 475.53 | 100 | 47,553 | 7,367 | 7.5 K to 7.4 K (-1.34 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 474.14 | 100 | 47,414 | 7,467 | 7.6 K to 7.5 K (-1.32 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 476.10 | 388 | 184,727 | 7,567 | 8 K to 7.6 K (-4.88 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 476.10 | 1,144 | 544,658 | 7,955 | 9.1 K to 8 K (-12.57 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Buy | M | 272.70 | 2,000 | 545,400 | 9,099 | 7.1 K to 9.1 K (+28.17 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | M | 272.70 | 2,000 | 545,400 | 64,000 | |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 473.57 | 226 | 107,027 | 7,099 | 7.3 K to 7.1 K (-3.09 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 472.54 | 100 | 47,254 | 7,325 | 7.4 K to 7.3 K (-1.35 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 471.00 | 100 | 47,100 | 7,425 | 7.5 K to 7.4 K (-1.33 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 469.91 | 100 | 46,991 | 7,525 | 7.6 K to 7.5 K (-1.31 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 466.98 | 307 | 143,363 | 7,625 | 7.9 K to 7.6 K (-3.87 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 466.98 | 1,167 | 544,966 | 7,932 | 9.1 K to 7.9 K (-12.83 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Buy | M | 272.70 | 2,000 | 545,400 | 9,099 | 7.1 K to 9.1 K (+28.17 %) |